КАЙЕНДРА

Описание товара

About КАЙЕНДРА

КАЙЕНДРА is a prescription medication containing the active ingredient Siponimod, used to treat secondary progressive multiple sclerosis (SPMS) in adults. It is a sphingosine 1-phosphate receptor modulator that helps to reduce the frequency of relapses and slow down disability progression.

Key Benefits & Uses

• Treatment of secondary progressive multiple sclerosis (SPMS) in adults
• Reduction of the frequency of relapses
• Slowing down disability progression

Active Ingredient & Action

Siponimod works by binding to sphingosine 1-phosphate receptors, which are involved in the migration of immune cells into the central nervous system. By modulating these receptors, Siponimod reduces the number of immune cells in the central nervous system, thereby reducing inflammation and slowing down disease progression.

Important Notes

КАЙЕНДРА should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Patients with a history of heart problems or other medical conditions should inform their doctor before starting treatment. Common side effects may include headache, fatigue, and increased liver enzymes.